Pfizer Inc. (PFE)

If you're looking to boost your passive income stream with dividend-paying stocks, there's a tough dilemma that we all face. Stocks that offer high yields generally do so because their dividend payout...

Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of course, they have the means to bounce back.

Pfizer crushed Q2 estimates with $14.7B revenue and $0.78 EPS, signaling a powerful turnaround driven by broad-based growth and operational excellence. A successful cost realignment program drove the ...

Pfizer said on Friday that its experimental sickle cell disease drug failed to meet the main goal in a late stage trial in patients 16 years of age and older.

Despite ongoing concerns about overvalued stocks, many value investors sleep well at night. That's because the key to long-term value investing is total return, which includes a healthy, growing divid...

Pfizer (PFE -0.18%) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine resulted in the business posting record sales and profits in 2022.

When it comes to picking stocks to buy in 2025, you need to look for stability and minimal volatility. The market has seen a lot of ups and downs this year, and building a portfolio that is resilient ...

Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired.

Pfizer's new and acquired drugs record sales of $4.7B in H1 as COVID-products related volatility eases.